Industry Annoyed Over Delay In Renewal Of Import Registration Licences By DCGI Office

The drug importers in the country are annoyed over what they termed as 'the avoidable delay' in the process of renewal of import registration licences by the office of the Drug Controller General of India (DCGI). The entire process which should not normally take more than two or three months now takes more than a year, for reasons best known to the authorities only.

According to sources in the industry, there is a lot of delay in renewing the import registration by the DCGI office, adversely affecting the business...

Medical Device Cos Want Export Council

The domestic medical devices industry has mooted the formation of a medical export council on the lines of Pharmexcil (Pharma Export Council), a body under the commerce ministry that represents the interest of pharma exporters...

DCGI Asks State DCs To Collect Data On Impact Of Revised Sch M Norms On SSIs

The Drugs Controller General (India) has asked all State drug controllers to collect the information on the closure of small scale pharma units following the amendment of the Drugs and Cosmetics Act enforcing the revised Schedule M guidelines in the country from July, 2005...

DoP Suggests Public Private Model For Development, Maintenance Of New NIPERs

The Department of Pharmaceuticals (DoP) which took the initiative of the project of establishing six new National Institutes of Pharmaceutical Education and Research (NIPERs) has suggested in its detailed project report that development and maintenance of infrastructural facilities should be under the Public Private Partnership (PPP) model...

Johnson & Johnson Net Up By 29.1% To US$ 4.5 Billion In Q1

Johnson & Johnson (J&J) has posted strong growth in net profit during the first quarter ended March 2010. Its net profit went up by 29.1 per cent to US$ 4,526 million from US$ 3,507 million in the similar period of last year. Its sales increased by 4 per cent to US$ 15,631 million from US$ 15,026 million...

BD Looking For New Growth Avenues In Emerging Markets, And India

The company, having established its plant in 1995 in India is looking for new growth avenues in emerging markets, and India. Its first office in the country was set up in 1995. BD’s India revenues, which topped $100 million in the past year, come from selling syringes, diagnostic kits, lab equipment and related gear used in healthcare. As growth prospects get bleaker at home, the company is looking for new growth avenues in emerging markets, and India, with its Rs. 5,750 Crore medical technology market looks attractive. Now the $7.1-billion giant wants to ramp up its development and manufacturing operations in India — it is shifting production from Sweden to India.

Researchers Make Artificial Blood Vessels From Jatropha Bhavnagar’s CSMCRI Develops Biodegradable Polymer

ARTIFICIAL blood vessels from jatropha? After bio-diesel, this humble tropical weed could now help Indian researchers to indigenously develop blood vessels.

Poly To Explore Global Medical Devices Market With Rs 100cr Investment

The New Delhi based PolyMedicure Pvt. Ltd., manufacturer and supplier of medical devices and disposables, is planning to invest Rs. 100 crore by 2013 to expand its presence in overseas market with a thrust on safety medical devices and outsourcing manufacturing and research activities.

TTK Healthcare To Grow Medical Devices Biz, Enters Orthopaedic Implants Market With US Tie-up

TTK Healthcare, a part of Rs 1500 crore TTK group and producing heart valves, has forayed into the orthopaedic implants segment dominated by players like Johnson & Johnson, Zimmer, Stryker and Indus.